JPRN-UMIN000049522已完成Unknown
Validation study on body fat-reducing effects by a long-term test-drink ingestion - Validation study on body fat-reducing effects by a long-term test-drink ingestion
CPCC Company Limited0 个研究点目标入组 80 人开始时间: 2023年11月22日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Subjects being under the restriction of meal with dieting (losing some weight by exercises and meal-controlling), and/or are planning to go on a diet. (2) Subjects taking steadily (over 3 times a week) in the following affecting foods (related to anti-obesity and lipid metabolism); health-specific, functional, supplementary, health foods, vitamin tablet and nutrient. (3) Subjects who have any difficulty in refraining from taking steadily in affecting medicines (e.g., anti-obesity and lipid metabolism). (4) Subjects who have taken affecting medicines (antibiotics) within the last month before the test-drink intakes, and planning to take those medicines. (5) Subjects with not less than 25.0 kg/m2 of BMI and not less than 100 cm2 of abdominal fat area, at the screening test. (6) Subjects with excessive alcohol intake. (7) Subjects with current and/or previous medical history of serious diseases in heart, liver, kidney and/or digestive organs. (8) Pregnant, lactating women, and possibly pregnant ones. (9) Subjects with drug and/or food allergy. (10) Subjects being under other clinical tests with some kind of medicine/food, or partook in those within four weeks before this study, or planning to join those after the consent. (11) Subjects who donated over 0.2 L of their blood and/or blood components within a month to this study. (12) Males who donated their whole blood (0.4 L) within the last three months to this study. (13) Females who donated their whole blood (0.4 L) within the last four months to this study. (14) Males who will be collected in total of their blood (1.2 L) within the last twelve months, after adding the blood amounts planning to be sampled in this study. (15) Females who will be collected in total of their blood (0.8 L) within the last twelve months, after adding the blood amounts planning to be sampled in this study. (16) Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinions.
研究者
相似试验
已完成
不适用
Verification test of body fat reduction effect by ingesting test foodhealthy participantsJPRN-UMIN000047267Medicial Corporation Kenshokai, Fukushima Healthcare Center75
已完成
不适用
Verification test of body fat-reducing effect of lactic acid bacterium containing foodsHealthy adultJPRN-UMIN000032404HUMA R&D CORP60
已完成
4 期
Study for the effect of visceral fat reduction by SGLT2 inhibitor Ipragliglozinin patients with type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000014058Hokkaido University Hospital26
尚未招募
Unknown
Visceral fat reduction effect verification test by ingestion of plant extracts -Placebo-controlled, randomized, double-blind, parallel-group comparison studyHealthy adultsJPRN-UMIN000053668KSO Corporation90
招募中
不适用
A human study to evaluate the body fat-lowering effect and safety of Lactobacillus plantarum CKDB156KCT0003944Seoul National University Bundang Hospital100
